Dynamic correlation of apoptosis and immune activation during treatment of HIV infection

Cell Death and Differentiation

Volumn 6, Issue 5, 1999, Pages 420-432

  Badley, Andrew D ^b   Parato, Karl ^c   Cameron, D William ^c   Kravcik, Stephen ^c   Phenix, Barbara N ^c   Ashby, Deborah ^c   Kumar, Ashok ^c   Lynch, David H ^a   Tschopp, Jurg ^c   Angel, Jonathan B ^c  

^a AMGEN INC   (United States)

^b UNIVERSITY OF OTTAWA   (Canada)

^c NONE

Author keywords

Activation; AICD; Apoptosis; Fas; FLIP; HIV

Indexed keywords

ANTIVIRUS AGENT; CD38 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; NELFINAVIR; PADGEM PROTEIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR;

ADULT; APOPTOSIS; ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; PRIORITY JOURNAL; T LYMPHOCYTE; VIREMIA;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0032989548     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400509     Document Type: Article

References (109)

1. Angel JB, Kumar A, Parato K, Filion LG, Diaz-Mitoma F, Daftarian P, Pham B, Sun E, Leonard JM and Cameron DW (1998) Improvement in cell-mediated immune function during potent anti-human immunodeficiency virus therapy with Ritonavir plus Saquinavir. J. Infect. Dis. 177: 898-904
2. Flexner C (1998) HIV-protease inhibitors. N. Engl. J. Med. 338: 1281-1292
3. + T-cell counts in HIV-infected patients. Ann. Intern. Med. 124: 1039-1050
4. Cameron DW, Heath-Chiozzi M, Danner S, Cohen C, Kravcik S, Maurath C, Sun E, Henry D, Rode R, Potthoff Aand Leonard J (1998) Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. Lancet 351: 543-549
5. Li CJ, Friedman DJ, Wang C, Metelev V and Pardee AB (1995) Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268: 429-431
6. Lederman MM, Connick E, Landay A, Kuritzkes DR, Spritzler J, St. Clair M, Kotzin BL, Fox L, Heath Chiozzi M, Leonard JM, Rousseau F, Wade M, Roe J, Martinez A and Kessler H (1998) Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of Zidovudine, Lamivudine, and Ritonavir: Results of AIDS Clinical Trials Group Protocol 315. J. Infect. Dis. 178: 70-79
7. Pakker NG, Notermans DW, de Boer RJ, Roos MTL, de Wolf F, Hill A, Leonard JM, Danner SA, Miedema F and Schellekens PTA (1998) Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation. Nature Med. 4: 208-214
8. + T cell homeostasis and function in advanced HIV disease. Science 277: 112-116
9. + repertoire during antiviral therapy. Nature Med. 4: 215-221
10. Kempf DJ, Marsh KC, Kumar G, Rodrigues AD, Denissen JF, McDonald E, Kuklka MJ, Hsu A, Grannemen GR, Baroldi PA, Sun E, Pizzuti D, Plattner JJ, Norbeck DW and Leonard JM (1997) Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir. Antimicrob. Agents Chemother. 41: 654-660
11. Badley AD, Dockrell D and Paya CV (1997) Apoptosis in AIDS. In Advances in Pharmacology, volume 4. Eds Kaufmann Scott H. 271-294
12. Clerici M, Sarin A, Henkart PA and Shearer GM (1997) Apoptotic cell death and cytokine dysregulation in human immunodeficiency virus infection: pivotal factors in disease progression. Cell Death Differ. 4: 699-706
13. Peter ME, Ehret A, Berndt C and Krammer PH (1997) AIDS and the death receptors. Brit. Med. Bul. 52: 604-616
14. Smith CA, Farrah T and Goodwin RG (1994) The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76: 959-962
15. Shimizu T and Pommier Y (1996) DNA fragmentation induced by protease activation in p53-null human leukemia HL60 cells undergoing apoptosis following treatment with the topoisomerase 1 inhibitor campothecin: cell-free system studies. Exp. Cell Res. 226: 292-301
16. Laurent-Crawford AG, Krust B, Muller S, Riviere Y, Rey-Culle MA, Bechel JM, Montagnier L and Howanessian AG (1991) The cytopathic effect of HIV is associated with apoptosis. Virol. 185: 829-839
17. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RPM and Miedema F (1992) Programmed cell death of T cells in HIV infection. Science 257: 217-219
18. + patients: Correlation with clinical progression and T cell loss. AIDS Res. Hum. Retro. 13: 1501-1508
19. +-T-cell counts, spontaneous apoptosis, and Fas expression in peripheral blood mononuclear cells obtained from human immunodeficiency virus type 1-infected subjects. Clin. Diag. Lab. Immunol. 4: 736-741
20. + cells during human immunodeficiency virus type 1 infection - correlation with clinical progression, viral load, and loss of humoral immunity. Virol. 238: 180-188
21. Liegler TJ, Yonemoto W, Elbeik T, Vittinghoff E, Buchbinder SP and Greene WC (1998) Diminished spontaneous apoptosis in lymphocytes from human immunodeficiency virus-infected long-term nonprogressors. J. Infect. Dis. 178: 669-679
22. Franceschi C, Grazia Franceschini M, Boschini A, Trenti T, Nuzzo C, Castellani G, Smacchia C, De Riezo B, Roncaglia R, Portolani M, Pictrosemoli P, Meacci M, Pecorari M, Sabbatini A, Malorni W and Cossarizza A (1997) Phenotypic characteristics and tendency to apoptosis of peripheral blood mononuclear cells from HIV+long term non progressors. Cell Death Differ. 4: 815-823
23. Badley AD, McElhinny JA, Leibson PJ, Lynch DH, Alderson MR and Paya CV (1996) Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J. Virol. 70: 199-206
24. + T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J. Exp. Med. 185: 55-64
25. + antigen-specific T cells to undergo apoptosis by HIV-infected monocytes. J. Clin. Invest. 99: 257-266
26. + T cells apoptosis. J. Immunol. 158: 2456-2463
27. Wu MX, Daley JF, Rasmussen RA and Schlossman SF (1995) Monocytes are required to prime peripheral blood T cells to undergo apoptosis. Proc. Natl. Acad. Sci. USA 92: 1525-1529
28. Orlikowsky T, Wang Z, Dudhane A, Horowitz H, Riethmuller G and Hoffman MK (1997) Cytotoxic monocytes in the blood of HIV type 1-infected subjects destroy targeted T cells in a CD95-dependent fashion. AIDS Res. Hum. Retro. 13: 953-960
29. + blood lymphocytes are rapidly killed in vitro by contact with autologous human immunodeficiency virus-infected cells. Proc. Natl. Acad. Sci. USA 92: 7312-7316
30. Herbein G, Van Lint C, Lovett JL and Verdin E (1998) Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes. J. Virol. 72: 660-670
31. Gehri R, Hahn S, Rothen M, Steurerwald M, Nuesch R and Erb P (1996) The Fas receptor in HIV infection: expression on peripheral blood lymphocytes and role in the depletion of T cells. AIDS 10: 9-16
32. + T cells from HIV-infected patients increases with disease progression. J. Mol. Med. 73: 591-593
33. Silvestris F, Cafforio P, Frassanito MA, Tucci M, Romito A, Nagata S, Dammacco F (1996) Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis. AIDS 10: 131-141
34. Kobayashi N, Hamamoto Y, Yamamoto N, Ishii A, Yonehara M and Yonehara S (1990) Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc. Natl. Acad. Sci. USA 87: 9620-9624
35. Westendorp MO, Frank R, Ochsenbauer K, Stricker K, Dhein J, Walczak H, Debatin K-M and Krammer PH (1995) Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375: 497-500
36. Katsikis PD, Wunderlich ES, Smith CA, Herzenberg LA and Herzenberg LA (1995) Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immuno-deficiency virus-infected individuals. J. Exp. Med. 181: 2029-2036
37. + T lymphocytes and accessory cells in lymphoid tissues. Proc. Natl. Acad. Sci. USA 93: 11057-11062
38. Finkel TH, Tudor-Williams G, Banda NK, Cotton MF, Curiel T, Monks C, Baba TW, Ruprecht RM and Kupfer A (1995) Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nature Med. 1: 129-134
39. Muro-Cacho CA, Pantaleo G and Fauci AS (1995) Analysis of apoptosis in lymph nodes of HIV-infected persons. J. Immunol. 154: 5555-5566
40. Badley AD, Dockrell DH, Algeciras A, Ziesmer S, Landay A, Lederman MM, Connick E, Kessler H, Kuritzkes D, Lynch DH, Roche P, Yagita H and Paya CV (1998) In vivo analysis of Fas/FasL interactions in HIV-infected patients. J. Clin. Invest. 102: 79-87
41. Dockrell DH, Badley AD, Villacian JS, Heppelmann CJ, Algeciras A, Ziesmer S, Yagita H, Lynch DH, Roche PC, Leibson PJ and Paya CV (1998) The expression of Fas ligand by macrophages and its upregulation by human immunodeficiency virus infection. J. Clin. Invest. 101: 2394-2405
42. Giorgi JV and Detels R (1989) T-cell subset alterations in HIV-infected homosexual men: NIAID multicenter AIDs cohort study. Clin, Immunol. Immunopathol. 52: 10-18
43. Giorgi JV, Liu Z, Hultin LE, Cumberland WG, Hennessen K and Detels R (1993) Elevated levels of CD38+CD8+ cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years follow-up. J. Acquir. Immune Defic. Syndr. 6: 904-912
44. Dhein J, Walczak H, Baumler C, Debatin K-M and Krammer PH (1995) Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373: 438-441
45. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell F and Lynch DH (1995) Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181: 71-77
46. Gougeon ML, Lecoeur H, Dulioust A, Enouf MG, Crouvoiser M, Goujard C, Debord T and Montagnier L (1996) Programmed cell death in peripheral lymphocytes from HIV-infected persons. J. Immunol. 156: 3509-3520
47. Katsikis PD, Garcia-Ojeda ME, Torres-Roca JF, Tijoe IM, Smith CA, Herzenberg LA and Herzenberg LA (1997) Interleukin-1Β converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection. J. Exp. Med. 186: 1365-1372
48. Katsikis PD, Garcia-Ojeda MC, Wunderlich ES, Smith CA, Yagita H, Okumura K, Kayagaki N, Alderson M, Herzenberg LA and Herzenberg LA (1996) Activation-induced peripheral blood T cell apoptosis is Fas independent in HIV-infected individuals. Int. Immunol. 8: 1311-1317
49. Algeciras A, Dockrell DH, Lynch DH and Paya CV (1998) CD4 regulates susceptibility to Fas ligand- and tumor necrosis factor-mediated apoptosis. J. Exp. Med. 187: 711-720
50. Giorgi JV, Ho HN, Hirji K, Chou CC, Hultin LE, O'Rourke S, Park L, Margolick JB, Ferbas J and Phair JP (1994) CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38-CD8+ cells is associated with subsequent stable CD4+ cell levels. J. Infect. Dis. 170: 775-781
51. Levacher M, Hulstaert F, Tallet S, Ullery S, Pocidalo JJ and Bach BA (1992) The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value. Clin. Exp. Immunol. 90: 376-382
52. Woods TC, Roberts BD, Butera ST and Folks TM (1997) Loss of inducible virus in CD45RA naive cells after human immunodeficiency virus-1 entry accounts for preferential viral replication in CD45RO memory cells. Blood 89: 1635-1641
53. Spina CA, Prince HE and Richman DD (1997) Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro. J. Clin. Invest. 99: 1774-1785
54. Roederer M, Raju PA, Mitra DK, Herzenberg LA and Herzenberg LA (1997) HIV does not replicate in naive CD4 T cells stimulated with CD3/CD28. J. Clin. Invest. 99: 1555-1564
55. Banda NK, Bernier J, Kurahara DK, Kurrle R, Haigwood N, Sekaly R-P and Finkel TH (1992) Cross-linking CD4 by human immunodeficiency virus gp120 primers T cells for activation-induced apoptosis. J. Exp. Med. 176: 1099-1106
56. Oyaizu N, McCloskey TW, Coronesi M, Chirmule VS, Kalyanaraman VS and Pahwa S (1993) Accelerated apoptosis in peripheral bood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 82: 3393-3400
57. Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA and Herzenberg LA (1995) CD8 naive T cells decrease progressively in HIV-irfected adults. J. Clin. Invest. 95: 2061-2066
58. Jenkins MK, Taylor PS, Norton SD and Urdahl KB (1991) CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J. Immunol. 147: 2461-2466
59. Azuma M, Cayabyak M, Buck D, Phillips JH and Lanier LL (1992) CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J. Exp. Med. 175: 353-360
60. Caruso A, Cantalamessa A, Licenziati S, Peroni L, Prati E, Martinelli F, Canaris AD, Folghera S, Gorla R, Balsari A and Turano A (1994) Expression of CD28 on CD8+ and CD4+ lymphocytes during HIV infection. Scandinavian J. Immunol. 40: 485-490
61. Choremi-Papadopoulou H, Viglis V, Gargalianos P, Kordossis T, Iniotaki-Theodoraki A and Kosmidis J (1994) Downregulation of CD28 surface antigen on CD4+ and CD8+ T lymphocytes during HIV-1 infection. J. Acquir. Immune. Defic. Syndr. 7: 245-253
62. Brinchmann JE, Dobloug JE, Heger BH, Haheim LL, Sannes M and Egeland T (1994) Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: functional and clinical correlations. J. Infect. Dis. 169: 730-738
63. 1/S transition to acquire susceptibility to Fas-mediated apoptosis. J. Immunol. 157: 4309-4315
64. Mollereau B, Blanchard D, Déas O, Dumont C, Métivier D, Bernard A, McGrew JT, Charpentier B, Vazquez A and Senik A (1997) Relationship between proliferation and susceptibility to CD95- and CD2-mediated apoptosis in stimulated primary T lymphocytes. J. Immunol. 159: 2668-2677
65. Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie A, Yonehara S and Taniguchi N (1992) Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol. 149: 3753-3758
66. + cells expressing gp160 of human immunodeficiency virus type 1. J. Virol. 68: 390-399
67. Wang Z, Dudhane A, Orlikowsky T, Clarke K, Li X, Darzynkiewicz Z and Hoffmann MK (1994) CD4 engagement induces Fas antigen-dependent apoptosis of T cells in vivo. Eur. J. Immunol. 24: 1549-1552
68. Liang K-Y and Zeger S (1986) Longitudinal data analysis using generalized linear models. Biometrika 73: 13-22
69. Zeger SL and Liang K-Y (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42: 121-130
70. Nagata S (1997) Apoptosis by death factor. Cell 88: 355-365
71. Klas C, Debatin KM, Jonker RR and Krammer PH (1993) Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5: 625-630
72. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer J-L, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE and Tschopp J (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388: 190-195
73. Copeland KF and Heeney JL (1996) T helper cell activation and human retroviral pathogenesis. Microbiol. Rev. 60: 722-742
74. Karmochkine M, Parizot C, Calvez V, Coutellier A, Herson S, Debre P and Gorochov G (1998) Susceptibility of peripheral blood mononuclear cells to apoptosis is correlated to plasma HIV load. J. AIDS 17: 419-423
75. Blanchard A, Montagnier L and Gougeon ML (1997) Influence of microbial infections on the progression of HIV disease. Trends in Microbiol. 5: 326-331
76. Cottrez F, Capron A and Groux H (1996) Selective CD4+ cell depletion after specific activation in HIV-infected individuals; protection by anti-CD28 monoclonal antibodies. Clin. Exp. Immunol. 105: 31-38
77. Gougeon ML, Lecoeur H, Boudet F, Ledru E, Marzabal S, Boullier S, Roue R, Nagata S and Heeney J (1997) Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype. J. Immunol. 158: 2964-2976
78. Zhang Y, Fadeel B, Hodara V and Fenyo E (1997) Induction of apoptosis by primary HIV-1 isolates correlates with productive infection in peripheral blood mononuclear cells. AIDS 11: 1219-1225
79. Glynn JM, McElligott DL and Mosier DE (1996) Apoptosis induced by HIV infection in H9 T cells is blocked by ICE-family protease inhibition but not by a Fas(CD95) antagonist. J. Immunol. 157: 2754-2758
80. + T lymphocytes is not mediated by Fas-Fas ligand. AIDS 11: 1671-1680
81. +T cells by a Fas-independent mechanism. J. Exp. Med. 187: 1113-1122
82. Konvalinda J, Litterst MA and Welker R (1995) An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity. J. Virol. 69: 7180-7186
83. Tomasselli AG, Hui JO, Adams L, Chosay J, Lowery D, Greenberg B, Yem A, Deibel MR, Zurcher-Neely H and Heinrickson RL (1991) Actin, troponin C, alzheimer amyloid precursor protein and pro-interleukin 1Β as substrates of the protease from human immunodeficiency virus. J. Biol. Chem. 266: 14548-14553
84. Strack PR, West Frey M, Rizzo CJ, Cordova B, George HJ, Meade R, Ho SP, Corman J, Tritch R and Korant BD (1996) Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2. Proc. Natl. Acad. Sci. USA 93: 9571-9576
85. Poon B, Grovit-Ferbas K, Stewart SA and Chen ISY (1998) Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents. Science 281: 266-269
86. Stewart SA, Poon B, Jowett JBM and Chen ISY (1997) Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J. Virol. 71: 5579-5592
87. Yao X-J, Mouland AJ, Subbramanian RA, Forget J, Rougeau N, Bergeron D and Cohen EA (1998) Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cells. J. Virol. 72: 4686-4693
88. Baur AS, Sawai ET, Dazin P, Fantl WJ, Cheng-Mayer C and Peterlin BM (1994) HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1: 373-384
89. Greenway A, Azad A and McPhee D (1995) Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. J. Virol. 69: 1842-1850
90. Okada H, Takei R and Tashiro M (1997) Nef protein of HIV-1 induces apoptotic cytolysis of murine lymphoid cells independently of CD95 (Fas) and its suppression by serine/threonine protein kinase inhibitors. FEBS Letters 417: 61-64
91. McCloskey TW, Ott M, Tribble E, Khan SA, Teichberg S, Paul MO, Pahwa S, Verdin E and Chirmule N (1997) Dual role of HIV Tat in regulation of apoptosis in T cells. J. Immunol. 158: 1014-1019
92. Li TS, Tubiana R, Katlama C, Calvez V, Ait Mohand H and Autran B (1998) Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 351: 1682-1686
93. Hanabuchi S, Koyanagi M, Kawasaki A, Shinohara N, Matsuzawa A, Nishimura Y, Kobayashi Y, Yonehara S, Yagita H and Okumura K (1994) Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA 91: 4930-4934
94. Yang BY, Mercep M, Ware CF and Ashwell JD (1995) Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: Inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J. Exp. Med. 181: 1673-1682
95. Ju S-T, Panka DJ, Cui H, Ettinger R, El-Khatib M, Sherr DH, Stanger BZ and Marshak-Rothstein A (1995) Fas (CD95)/Fas L interactions required for programmed cell death after T-cell activation. Nature 373: 444-448
96. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175: 331-340
97. Jeremias I, Herr I, Boehler T and Debatin K-M (1998) TRAIL/Apo-2-ligand-induced apoptosis in human T cells. Eur. J. Immunol. 28: 143-152
98. Kaplan D and Sieg S (1998) Role of the Fas/Fas ligand apoptotic pathway in human immunodeficiency virus type 1 disease. J. Virol. 72: 6279-6282
99. Mitra D, Steiner D, Lynch DH, Staiano-Coico L and Laurence J (1996) HIV-1 upregulates Fas ligand expression in CD4+ T cells in vitro and in vivo: association with Fas-mediated apoptosis and modulation by aurintricarboxylic acid. Immunol. 87: 581-585
100. Reed JC (1994) Bcl-2 and the regulation of programmed cell death. J. Cell. Biol. 124: 1-6
101. Hu S, Vincenz C, Ni J, Gentz R and Dixit VM (1997) I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95-induced apoptosis. J. Biol. Chem. 272: 17255-17257
102. Inohara N, Koseki T, Hu Y, Chen S and Nunez G (1997) CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis. Proc. Natl. Acad. Sci. USA 94: 10717-10722
103. Andre P, Groettrup M, Klenerman P, de Guilit R, Booth BL Jr, Cerundolo V, Bonneville M, Jotereault F, Zinkernagel RM and Lotteau V (1998) An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses. Proc. Natl. Acad. Sci. USA 95: 13120-13124
104. Collier AC, Coombs RW, Schoenfeld DA, Bassett RL, Timpone J, Baruch A, Jones M, Facey K, Whitacre C, McAuliffe VJ, Friedman HM, Merigan TC, Reichman RC, Hooper C and Corey L. (1996) Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. N. Engl. J. Med. 334: 1011-1017
105. Kaufmann D, Pantaleo G, Sudre P and Telenti A for the Swiss HIV Cohort Study. Research Letters. (1998) CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antriretroviral therapy (HAART). Lancet 351: 723-724
106. Levitz SM (1998) Improvement in CD4+ cell counts despite persistently detectable HIV load. N. Engl. J. Med. 338: 1074-1075
107. Cohen J (1998) Failure isn't what it used to be . . . but neither is success. Science 279: 1074-1134
108. Carr A, Emery S, Kelleher A, Law M and Cooper DA (1996) CD8+ lymphocyte responses to antiretroviral therapy of HIV infection. J. Acquir. Immune Defic. Syndr. 13: 320-326
109. Naito M, Nagashima K, Mashima T and Tsuruo T (1997) Phosphatidylserine externationization is a downstream event of interleukin-1Β-converting enzyme family protease activation during apoptosis. Blood 89: 2060-2066